14 insiders have filed at XENE since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Azab Mohammad | Director | 74.2k | 0.085% | ||
| Mortimer Ian | President & CEO | 34.2k | 0.039% | 22 sells $23.5M | |
| Patou Gary | Director | 28.5k | 0.033% | 6 sells $960k | |
| Svoronos Dawn | Director | 25.0k | 0.029% | 1 sells $968k | |
| Robin Sherrington | EVP, Strategy & Innovation | 8.4k | 0.01% | 2 sells $330k | |
| Difabio Andrea | Chief Legal Officer | 7.3k | <0.01% | 2 sells $231k | |
| Gannon Steven | Director | 7.1k | <0.01% | 5 sells $602k | |
| Kenney Christopher John | Chief Medical Officer | 7.1k | <0.01% | 2 sells $244k | |
| Gover Justin D. | Director | ||||
| Cannon Gillian | Director | ||||
| Garofalo Elizabeth A. | Director | 1 sells $96k | |||
| Aulin Sherry | Chief Financial Officer | 2 sells $771k | |||
| Cline Darren S | Chief Commercial Officer | ||||
| Kelly Thomas Patrick | Chief Financial Officer |
Full register at boothcheck.com/insiders/XENE. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.